Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

450
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
450
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

228
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
228
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

230
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
230
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

782
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
782
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

50
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
50
Renal Corpuscle01:20

Renal Corpuscle

4.7K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis.

Clinical journal of the American Society of Nephrology : CJASN·2024
Same author

Pregnancy outcome in patients with a medical history of immunoglobulin A vasculitis: a case-control study.

Scandinavian journal of rheumatology·2023
Same author

IgA vasculitis.

Seminars in immunopathology·2021
See all related articles

Related Experiment Video

Updated: Nov 3, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.0K

IgA Vasculitis and IgA Nephropathy: Same Disease?

Evangeline Pillebout1,2

  • 1Nephrology Unit, Saint-Louis Hospital, 75010 Paris, France.

Journal of Clinical Medicine
|June 2, 2021
PubMed
Summary

IgA Vasculitis (IgAV) and IgA Nephropathy (IgAN) may be manifestations of the same disease spectrum. Further research is needed to understand why some patients develop skin lesions while others develop kidney disease.

Keywords:
IgA NephropathyIgA Vasculitisadultschildrengeneticsphysiopathologypresentationprognosistreatment

More Related Videos

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

2.0K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.4K

Related Experiment Videos

Last Updated: Nov 3, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.0K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

2.0K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.4K

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • IgA Vasculitis (IgAV) and IgA Nephropathy (IgAN) are hypothesized to be related, potentially as systemic vs. renal manifestations of a single disease.
  • Limited studies have comprehensively compared IgAV and IgAN in children and adults regarding clinical, biological, histological, and prognostic aspects.
  • Current IgAN therapeutic trials exclude patients with vasculitis, hindering comparative treatment research.

Purpose of the Study:

  • To explore the relationship between IgA Vasculitis and IgA Nephropathy.
  • To identify similarities and differences in clinical presentation, pathophysiology, genetics, and prognosis between IgAV and IgAN.
  • To address the unresolved question of why some IgAN patients lack skin lesions and some IgAV patients lack nephropathy.

Main Methods:

  • Review of existing literature and clinical studies comparing IgAV and IgAN.
  • Analysis of diagnostic criteria and disease progression in patients with IgAV and IgAN.
  • Consideration of genetic background and age stratification in disease manifestation.

Main Results:

  • IgAV is often diagnosed early due to characteristic skin rash, while IgAN diagnosis relies on renal biopsy, potentially leading to delayed detection of chronic kidney lesions.
  • The distinct clinical presentations (skin vs. kidney involvement) suggest different disease expressions within a potential spectrum.
  • The underlying reasons for the selective absence of skin lesions in IgAN and renal involvement in IgAV remain unclear.

Conclusions:

  • IgAV and IgAN might represent different ends of a disease spectrum, necessitating further investigation.
  • Larger, collaborative studies are required to establish a common histological classification and stratify patients by age and genetics.
  • Future research should focus on understanding the differential manifestations and developing targeted therapeutic strategies for both conditions.